The Company:
With deep expertise in chemistry, Nuvalent is working to create selective medicines designed with the goal to address the needs of patients with cancer. Nuvalent is an exciting early-stage company, bringing together experienced scientists and industry veterans with a proven track record in drug discovery, oncology drug development, and company building.
The Role:
Reporting to the Vice President, Marketing, the Director of Brand Strategy will contribute significantly to the success of the company’s first commercial launches by leading commercial strategy workstreams across the portfolio, including annual brand planning (i.e., strategic and budget planning), ongoing budget management, and insight / performance evaluation, among others. This individual will be a critical member of the Marketing Team and Integrated Brand Team, working closely with cross-functional stakeholders on highly collaborative workstreams with significant organizational visibility.
Responsibilities:
• Collaborate with Brand Lead, Digital Marketing Lead, Medical Affairs, Sales, and Market Access to lead development of cross-functional Brand / Launch plan outlining Brand Strategy, supporting tactics, clear budget allocation, and KPIs.
• Lead development and ongoing management of annual Marketing budget in collaboration with Marketing Team colleagues, adapting / optimizing as needed.
• Collaborate with Marketing colleagues (e.g., HCP Marketing, Patient Marketing) and other cross-functional stakeholders (e.g., Medical Affairs, Market Research) to organize, gather, and analyze Commercial insights for zidesamtinib and neladalkib, including identification of critical insight gaps, creation of market research plans to fill gaps, assessment / synthesis of insights, and development of strategic implications / recommendations
• Collaborate with Insights / Analytics on ongoing performance measurement / KPI tracking and synthesize strategic implications / recommendations.
• Collaborate with Corporate Strategy / Competitive Intelligence to lead cross-functional competitive planning and ensure preparedness for the Integrated Brand Team
• Lead cross-functional coordination of organizational responses to key market events (e.g., competitor data sets / approvals, Nuvalent product approvals).
• Commercial representation on the Neladalkib Product Development Team
• Collaborate with VP of Marketing, Corporate Strategy, and Forecasting to contribute to assessment / recommendations of LCM opportunities and relevant business cases.
• Collaborate with senior stakeholders and peers to contribute to upward communication (e.g., Board of Directors presentation).
Competencies Include:
• Exceptional problem-solving, analytical, and organizational skills
• Exceptional facilitation, collaboration, verbal, presentation, and written skills
• Strong emotional intelligence, tact, and ability to influence others without direct authority
• Fast learner, self-directed / self-driven, diplomatic, and entrepreneurial
• Highly motivated to support Team, Brand, and Company success and deliver for Patients
• Flexibility to work both independently and in close collaboration with peers and senior stakeholders
• Strong ability to adapt to evolving conditions as needed in a dynamic, fast-paced environment
• Strong scientific and clinical orientation, comfortable with qualitative / quantitative / clinical data, and able to analyze / distill complex information into business implications / recommendations and credible narrative with internal and external stakeholders
• Proficiency with Excel, Microsoft Word, PowerPoint, Teams / Zoom
Qualifications:
• Bachelor’s degree required
• 10+ years of biopharma commercial experience; prior consulting and oncology experience preferred
• Product launch experience, preferably in oncology
• Patient and HCP marketing experience
• Highly experienced in problem-solving, qualitative / quantitative data analysis, and strategy
• Demonstrated success in leading cross-functional workstreams, collaborating closely with peers and senior stakeholders, and creating / delivering presentations to diverse audiences
• Proven ability to manage multiple projects simultaneously, prioritize effectively, and rapidly adapt to change
• Willingness to travel domestically up to 20%
Nuvalent provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to religion, race, creed, color, sex, sexual orientation, alienage or citizenship status, national origin, age, marital status, pregnancy, disability, veteran or military status, predisposing genetic characteristics or any other characteristic protected by applicable federal, state or local law.
Nuvalent is aware that many companies are dealing with fraudulent job postings on third-party employment search sites and/or individual(s) or entities claiming to be employees of such companies. Those involved are offering fraudulent employment opportunities to applicants, often asking for sensitive personal and financial information, and using such information for criminal activities.
Please be advised that all legitimate correspondence from a Nuvalent employee will come from "@nuvalent.com" email accounts. Automated system response emails from our Greenhouse applicant tracking system come from a “[email protected]” email address. There are no variations of these email addresses and Nuvalent would not request personal and/or financial information via email. Job opportunities would only be extended after a completed job application is submitted by a candidate and a thorough interview process including 1:1 and/or group interviews via phone, video conferencing and/or in-person.
If you believe you have been contacted by anyone misrepresenting themselves as an employee of Nuvalent, please contact Nuvalent at 857-357-7000. Thank you.
What We Do
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses. Nuvalent is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive NSCLC, along with multiple discovery-stage research programs. To learn more, visit www.nuvalent.com.
